A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Boehringer Ingelheim
Revolution Medicines, Inc.
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Replimune Inc.
University of Nebraska